RxDoctor Payments Data

Haley Clark

Physician Assistant · Waynesburg, KYNPI 1326417023

Payments from drug & device makers

$2,140in general payments, 2019–2025

Across 148 payments — averaging $14.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$623
  • Amgen$281
  • Lilly USA, LLC$141
  • Bayer$140
  • Biohaven Pharmaceutical Holding Company Ltd.$130
  • Agile Therapeutics, Inc.$104
  • plus $721 from 16 others

What the payments were for

  • Food & beverage$2,140100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,140 in reported general payments places this provider in the 80th percentile of 1,448 physician assistant providers in Kentucky.

See all physician assistant providers in Kentucky

Medicare billing

Part B allowed, 2024
$1,320
Medicare patients
17
Services billed
25

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide56$66,052
Trelegy ElliptaFluticasone/Umeclidin/Vilanter48$41,888
JanuviaSitagliptin Phosphate16$23,097
Nurtec OdtRimegepant Sulfate14$20,090
MounjaroTirzepatide13$17,449
Tresiba Flextouch U-200Insulin Degludec11$15,316
EliquisApixaban14$12,715
Breo ElliptaFluticasone/Vilanterol27$12,482
FarxigaDapagliflozin Propanediol20$12,343
SymbicortBudesonide/Formoterol Fumarate23$8,824
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog16$8,623
Spiriva HandihalerTiotropium Bromide11$7,449
KerendiaFinerenone11$6,961
JanumetSitagliptin Phos/Metformin Hcl11$6,188
BreynaBudesonide/Formoterol Fumarate21$3,728

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$80$54,37075 claims
PfizerNurtec Odt, Eliquis$57$32,80528 claims
AstraZenecaFarxiga, Symbicort$53$21,16743 claims
Lilly USA, LLCMounjaro$141$17,44913 claims
BayerKerendia$140$6,96111 claims
AbbVieSynthroid$623$89015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,448 physician assistant providers in Kentucky.

Other physician assistant in Waynesburg

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →